Fabı́ola Traina

4.3k citations

160 papers · 2.6k indexed · h-index 28

Impact in

Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders

Papers in ⓘ

Hematology 113
- Acute Myeloid Leukemia Research 76
- Chronic Myeloid Leukemia Treatments 23
Genetics 71
- Myeloproliferative Neoplasms: Diagnosis and Treatment 33
- Hemoglobinopathies and Related Disorders 26
- Chronic Lymphocytic Leukemia Research 13

Co-authors: Sara Teresinha Olalla Saad (65 shared papers)João Agostinho Machado‐Neto (72 shared papers)Fernando Ferreira Costa (46 shared papers)Patrícia Favaro (25 shared papers)Ramón V. Tiu (14 shared papers)Valeria Visconte (11 shared papers)Nicola Conran (15 shared papers)Mikkael A. Sekeres (10 shared papers)
Journals: Blood (32 papers)Leukemia Research (11 papers)Scientific Reports (5 papers)Haematologica (5 papers)PLoS ONE (5 papers)
Partner nations: Brazil United States United Kingdom

In The Last Decade

Fabı́ola Traina

146 papers receiving 2.5k citations

Peers

Countries citing papers authored by Fabı́ola Traina

Since Specialization

Citations

This map shows the geographic impact of Fabı́ola Traina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabı́ola Traina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabı́ola Traina more than expected).

Fields of papers citing papers by Fabı́ola Traina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabı́ola Traina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabı́ola Traina. The network helps show where Fabı́ola Traina may publish in the future.

Co-authors

The 25 scholars most cited alongside Fabı́ola Traina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fabı́ola Traina Line = papers co-authored together Fabı́ola Traina links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A Blood ·A. Jankowska, Hideki Makishima, Ramón V. Tiu, Hadrian Szpurka, Yun Huang, Fabı́ola Traina, Valeria Visconte, Yuka Sugimoto, Courtney Prince, Christine L. O’Keefe, Eric D. Hsi, Alan F. List, Mikkael A. Sekeres, Anjana Rao, Michael A. McDevitt, Jaroslaw P. Maciejewski	2011	238
2	Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms Leukemia ·Fabı́ola Traina, Valeria Visconte, Paul Elson, Ali Tabarroki, Ania Jankowska, Edy Hasrouni, Yuka Sugimoto, Hadrian Szpurka, Hideki Makishima, C. O'Keefe, Mikkael A. Sekeres, Anjali S. Advani, M. Kalaycio, Edward A. Copelan, Yogen Saunthararajah, Sara Teresinha Olalla Saad, J. Maciejewski, Ramón V. Tiu	2013	219
3	Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis PLoS ONE ·Fabı́ola Traina, Valeria Visconte, A. Jankowska, Hideki Makishima, Christine L. O’Keefe, Paul Elson, Yingchun Han, Fred H. Hsieh, Mikkael A. Sekeres, Raghuveer Singh Mali, Matt Kalaycio, Alan Lichtin, Anjali S. Advani, Hien K. Duong, Edward A. Copelan, Reuben Kapur, Sara Teresinha Olalla Saad, Jaroslaw P. Maciejewski, Ramón V. Tiu	2012	86
4	Rho Kinase Regulates the Survival and Transformation of Cells Bearing Oncogenic Forms of KIT, FLT3, and BCR-ABL Cancer Cell ·Raghuveer Singh Mali, Baskar Ramdas, Peilin Ma, Jianjian Shi, Veerendra Munugalavadla, Emily Sims, Lei Wei, Sasidhar Vemula, Sarah C. Nabinger, Charles B. Goodwin, Rebecca J. Chan, Fabı́ola Traina, Valeria Visconte, Ramón V. Tiu, Timothy A. Lewis, Andrew M. Stern, Qiang Wen, John D. Crispino, H. Scott Boswell, Reuben Kapur	2011	79
5	Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia Haematologica ·Sarah Abu Kar, Ania Jankowska, Hirokazu Makishima, V. Visconte, Andrés Jerez, Yuka Sugimoto, Hideki Muramatsu, Fabı́ola Traina, Manuel Afable, Kathryn M Guinta, Ramón V. Tiu, Bartlomiej Przychodzen, Hirotoshi Sakaguchi, Seiji Kojima, Mikkael A. Sekeres, Alan F. List, Michael A. McDevitt, Jaroslaw P. Maciejewski	2012	61
6	ARHGAP21 is a RhoGAP for RhoA and RhoC with a role in proliferation and migration of prostate adenocarcinoma cells Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Mariana Lazarini, Fabı́ola Traina, João Agostinho Machado‐Neto, Karin Spat Albino Barcellos, Yuri B. Moreira, Marcelo Mendes Brandão, Sergio Verjovski‐Almeida, Anne J. Ridley, Sara Teresinha Olalla Saad	2012	48
7	CXCR7 Is Highly Expressed in Acute Lymphoblastic Leukemia and Potentiates CXCR4 Response to CXCL12 PLoS ONE ·Rita de Cássia Carvalho Melo, Ana Leda F. Longhini, Carolina L. Bigarella, Mariana Ozello Baratti, Fabı́ola Traina, Patrícia Favaro, Paula de Melo Campos, Sara Teresinha Olalla Saad	2014	47
8	Expansion strategies for human mesenchymal stromal cells culture under xeno‐free conditions Biotechnology Progress ·Patrícia A. Tozetti, Sâmia Rigotto Caruso, Amanda Mizukami, Taísa Risque Fernandes, Fernanda Borges da Silva, Fabı́ola Traina, Dimas Tadeu Covas, Maristela Delgado Orellana, Kamilla Swiech	2017	47
9	Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties European Journal Of Haematology ·Sheley Gambero, Andréia A. Canalli, Fabı́ola Traina, Dulcinéia Martins de Albuquerque, Sara T. Olalla Saad, Fernando Ferreira Costa, Nicola Conran	2006	42
10	FMNL1 promotes proliferation and migration of leukemia cells Journal of Leukocyte Biology ·Patrícia Favaro, Fabı́ola Traina, João Agostinho Machado‐Neto, Mariana Lazarini, Matheus Rodrigues Lopes, João Kleber Novais Pereira, Fernando Ferreira Costa, Elvira Infante, Anne J. Ridley, Sara Teresinha Olalla Saad	2013	42
11	Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis Clinics ·João Agostinho Machado‐Neto, Bruna Alves Fenerich, Ana Paula Nunes Rodrigues Alves, Jaqueline Cristina Fernandes, Renata Scopim‐Ribeiro, Juan Luiz Coelho‐Silva, Fabı́ola Traina	2018	41
12	ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells Experimental Cell Research ·João Agostinho Machado‐Neto, Mariana Lazarini, Patrícia Favaro, Gilberto C. Franchi, Alexandre E. Nowill, Sara Teresinha Olalla Saad, Fabı́ola Traina	2014	40
13	Human leukocyte formin: a novel protein expressed in lymphoid malignancies and associated with Akt Biochemical and Biophysical Research Communications ·Patrícia Favaro, Samuel de Souza Medina, Fabı́ola Traina, Daniela S. Daniela Sanchez Bassères, Fernando Ferreira Costa, Sara Teresinha Olalla Saad	2003	39
14	Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning Bone Marrow Transplantation ·Mary E.D. Flowers, Fabı́ola Traina, Barry E. Storer, Michael B. Maris, Wolfgang Bethge, Paul A. Carpenter, F R Appelbaum, Rainer Storb, Brenda M. Sandmaier, Paul J. Martin	2004	38
15	Endothelial Activation by Platelets from Sickle Cell Anemia Patients PLoS ONE ·Renata Proença‐Ferreira, Ana Flávia Brugnerotto, Vanessa T. Garrido, Venina Marcela Dominical, Daiana Morelli Vital, Marilene de Fátima Reis Ribeiro, Melissa Ercolin dos Santos, Fabı́ola Traina, Sara Teresinha Olalla Saad, Fernando Ferreira Costa, Nicola Conran	2014	38
16	Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 Leukemia Research ·Paula de Melo Campos, João Agostinho Machado‐Neto, Renata Scopim‐Ribeiro, Valeria Visconte, Ali Tabarroki, Adriana Silva Santos Duarte, Flávia F.C. Barra, José Vassalo, Heesun J. Rogers, Irene Lorand‐Metze, Ramón V. Tiu, Fernando Ferreira Costa, Sara Teresinha Olalla Saad, Fabı́ola Traina	2014	35
17	Stathmin 1 in normal and malignant hematopoiesis BMB Reports ·João Agostinho Machado‐Neto, Sara Teresinha Olalla Saad, Fabı́ola Traina	2014	35
18	Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation Hematology Transfusion and Cell Therapy ·Maira da Costa Cacemiro, Juçara Gastaldi Cominal, Raquel Tognon, Natália de Souza Nunes, Belinda Pinto Simões, Lorena Lôbo de Figueiredo-Pontes, Luiz Fernando Bazzo Catto, Fabı́ola Traina, Elizabeth Xisto Souto, Fabiana Albani Zambuzi, Fabiani Gai Frantz, Fabíola Attié de Castro	2018	33
19	Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea Haematologica ·Flávia Cristine Mascia Lopes, Fabı́ola Traina, Camila Bononi Almeida, Flávia C. Leonardo, Carla Fernanda Franco‐Penteado, Vanessa T. Garrido, Marina Pereira Colella, Raquel Soares, Sara Teresinha Olalla Saad, F. F. Costa, Nicola Conran	2015	33
20	IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells Cancer Letters ·Ana Paula Nunes Rodrigues Alves, Jaqueline Cristina Fernandes, Bruna Alves Fenerich, Juan Luiz Coelho‐Silva, Priscila Santos Scheucher, Belinda Pinto Simões, Eduardo Magalhães Rego, Anne J. Ridley, João Agostinho Machado‐Neto, Fabı́ola Traina	2019	32

About Fabı́ola Traina

Fabı́ola Traina is a scholar working on Hematology, Genetics, Molecular Biology, Immunology and Rheumatology, having authored 160 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (76 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers), Hemoglobinopathies and Related Disorders (26 papers), Chronic Myeloid Leukemia Treatments (23 papers), Acute Lymphoblastic Leukemia research (16 papers), Chronic Lymphocytic Leukemia Research (13 papers), Erythrocyte Function and Pathophysiology (13 papers) and Epigenetics and DNA Methylation (12 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (909 citations), Molecular Biology (1.2k citations), Immunology (369 citations) and Cancer Research (239 citations). Fabı́ola Traina has collaborated with scholars based in Brazil, United States and United Kingdom. Frequent co-authors include Sara Teresinha Olalla Saad, João Agostinho Machado‐Neto, Fernando Ferreira Costa, Patrícia Favaro, Ramón V. Tiu, Valeria Visconte, Nicola Conran, Mikkael A. Sekeres, Paula de Melo Campos and Hideki Makishima. Their work appears in journals such as Blood, Leukemia Research, Scientific Reports, Haematologica and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact